Samsung will be launching new smartwatch models alongside its next-generation foldable smartphones at the upcoming Galaxy Unpacked. The Samsung Galaxy Watch 7 series models are rumored to arrive with multiple new health features, including a blood glucose monitoring feature. Now, a new report claims that the upcoming smartwatch will also be able to track early signs of heart attack, stroke, and diabetes.
Health features coming to the Samsung Galaxy Watch 7: What to expect
According to a report by Android Authority, evidence has been spotted that the company is implementing an AGEs index for the Galaxy Watch 7 in the latest version of the Samsung Health app. This could help the smartwatch model offer cardiovascular and diabetes risk tracking.
According to the report, the Samsung Health app also enabled the user interface for the new feature called AGEs index. The report also includes a screenshot where the AGEs index feature is marked as (Labs), indicating that it is in an experimental state.
The screenshot text mentions that Samsung Health will soon offer a way to track a user’s AGEs over time by creating an index of readings. This AGE index will give users insight into their personal metabolic health (rather than a measurement number that would be difficult to contextualize) and help them learn more about their overall biological aging process.
What is the AGE index?
The advanced glycation end products (AGE) index has been linked to a variety of chronic diseases that become more common with age, such as diabetes, kidney failure and heart problems.
Diagnoptics (Samsung’s purported partner for measuring AGEs) has highlighted that these compounds play a key role in the development of these diseases, the report added. Diagnoptics also suggested that AGEs can be used to predict the risk of diabetes, heart attack and stroke.
It is important to note that AGEs accumulate naturally with age, but their levels can be reduced through regular exercise. Diagnoptics also mentioned that many AGEs have a specific glow (fluorescence). This feature allows for noninvasive measurement of these compounds.
The report claims that Galaxy Watch 7 series models could include a way to measure these AGEs optically and non-invasively. These readings are expected to form the basis of the AGE index and allow users to monitor their risk of certain diseases, such as diabetes, without needing to actively provide them with a measurement value.
This report also coincides with rumors about “blood glucose monitoring” on Samsung Galaxy Watch 7 models, which could provide clues to diabetes risk rather than actively monitoring blood glucose levels. In five years, noninvasive glucose monitoring is likely to hit the market in “some form,” Bloomberg reports.
Additionally, the report could not confirm whether older Galaxy Watch models will support AGE features or whether the Galaxy Watch 7 will support continuous glucose monitoring.
Health features coming to the Samsung Galaxy Watch 7: What to expect
According to a report by Android Authority, evidence has been spotted that the company is implementing an AGEs index for the Galaxy Watch 7 in the latest version of the Samsung Health app. This could help the smartwatch model offer cardiovascular and diabetes risk tracking.
According to the report, the Samsung Health app also enabled the user interface for the new feature called AGEs index. The report also includes a screenshot where the AGEs index feature is marked as (Labs), indicating that it is in an experimental state.
The screenshot text mentions that Samsung Health will soon offer a way to track a user’s AGEs over time by creating an index of readings. This AGE index will give users insight into their personal metabolic health (rather than a measurement number that would be difficult to contextualize) and help them learn more about their overall biological aging process.
What is the AGE index?
The advanced glycation end products (AGE) index has been linked to a variety of chronic diseases that become more common with age, such as diabetes, kidney failure and heart problems.
Diagnoptics (Samsung’s purported partner for measuring AGEs) has highlighted that these compounds play a key role in the development of these diseases, the report added. Diagnoptics also suggested that AGEs can be used to predict the risk of diabetes, heart attack and stroke.
It is important to note that AGEs accumulate naturally with age, but their levels can be reduced through regular exercise. Diagnoptics also mentioned that many AGEs have a specific glow (fluorescence). This feature allows for noninvasive measurement of these compounds.
The report claims that Galaxy Watch 7 series models could include a way to measure these AGEs optically and non-invasively. These readings are expected to form the basis of the AGE index and allow users to monitor their risk of certain diseases, such as diabetes, without needing to actively provide them with a measurement value.
This report also coincides with rumors about “blood glucose monitoring” on Samsung Galaxy Watch 7 models, which could provide clues to diabetes risk rather than actively monitoring blood glucose levels. In five years, noninvasive glucose monitoring is likely to hit the market in “some form,” Bloomberg reports.
Additionally, the report could not confirm whether older Galaxy Watch models will support AGE features or whether the Galaxy Watch 7 will support continuous glucose monitoring.
